This is the second antibody development collaboration between Ono and Medarex. Anti-SDF-1 antibodies have been raised utilizing Medarex’s UltiMAb human antibody development system. Under this collaboration, Ono and
Arthritis and most rheumatic diseases often result in inflammation, cartilage and bone erosions. While inflammation may be controlled, and perhaps even eliminated, with early aggressive treatment, few therapeutic
Although financial details of the agreement were not disclosed, the deal builds on the existing relationship between Roche and BioFocus. Under the terms of the agreement, BioFocus will
The double-blind, placebo-controlled clinical study is designed to assess the safety, tolerability and pharmacokinetics of a subcutaneous injection of PulmoLar. PulmoLar is PRP’s proprietary sustained-release injectable formulation of
The phase II trial is designed to enroll approximately 130 patients with diabetes who have clinically significant protein in the urine (proteinuria). Participants will be randomly assigned to
In the European Union, it is estimated that nearly 12 million patients suffer from generalized anxiety disorder (GAD) on a yearly basis yet only one-third of these patients
The new approval means Aranesp (darbepoetin alfa) can be used every three weeks for patients with non-myeloid malignancies experiencing anemia (low red blood cell count), rather than being
The study is planned to enroll approximately 270 HIV/AIDS patients at multiple sites in the US and Latin America and will provide essential data for Immtech’s first new
Researchers from the Rubin Institute for Advanced Orthopaedics at Sinai Hospital of Baltimore conducted the study demonstrating that the use of TissueLink’s saline-enhanced radiofrequency technology was associated with
Pouchitis is a debilitating gastrointestinal disorder that can develop following corrective surgical treatment of ulcerative colitis. There are no currently approved treatments for pouchitis and management of the
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.